Sharon Townson, Chief Scientific Officer at Monte Rosa Therapeutics ($GLUE), sold shares once on the open market in the last year, totaling $47,861. Her most recent sale occurred on January 5, 2026. These sales rank her 10,439th among 11,678 insiders by value, well below the average of $8.6 million per seller across 6 transactions. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Monte Rosa Therapeutics, Inc. | $GLUE | Townson Sharon | Chief Scientific Officer | A | Common Stock | 35000 | $0.00 | 71,000.0000 | 82,942,723 | 97.22% | 0.04% |
| Jan. 5, 2026 | Monte Rosa Therapeutics, Inc. | $GLUE | Townson Sharon | Chief Scientific Officer | S | Common Stock | 3155 | $15.17 | 67,845.0000 | 82,942,723 | 4.44% | 0.00% |
| Jan. 2, 2026 | Monte Rosa Therapeutics, Inc. | $GLUE | Townson Sharon | Chief Scientific Officer | A | Stock Option (Right to Buy) | 158000 | $0.00 | 158,000.0000 | 82,942,723 | 9999.99% | 0.19% |
| Jan. 2, 2025 | Monte Rosa Therapeutics, Inc. | $GLUE | Townson Sharon | Chief Scientific Officer | A | Common Stock | 36000 | $0.00 | 36,000.0000 | 73,910,026 | 9999.99% | 0.05% |
| Jan. 2, 2025 | Monte Rosa Therapeutics, Inc. | $GLUE | Townson Sharon | Chief Scientific Officer | A | Stock Option (Right to Buy) | 161000 | $0.00 | 161,000.0000 | 73,910,026 | 9999.99% | 0.22% |
| June 3, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Townson Sharon | Chief Scientific Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 51,396,961 | 9999.99% | 0.08% |